Ginkgo biloba
- Generic Name
- Ginkgo biloba
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 90045-36-6
- Unique Ingredient Identifier
- 19FUJ2C58T
- Background
Ginkgo biloba extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties. Most of the studies that investigate the effect of ginkgo biloba use the standardized extract of Ginkgo biloba (EGb) 761 (EGb761), wh...
- Indication
Ginkgo biloba does not currently have any approved therapeutic indications, and there is insufficient evidence to support its unapproved use. It is available in over-the-counter herbal products mostly for oral use, to improve memory and cognitive problems.
- Associated Conditions
- Cognitive Dysfunctions, Cognitive Functioning, Depression
- Associated Therapies
- -
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2016-10-25
- Lead Sponsor
- Seoul National University Hospital
- Registration Number
- NCT01663467
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Ginkgo Biloba Extract for Schizophrenia
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- Beijing HuiLongGuan Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT01524380
- Locations
- 🇨🇳
Beijing HuiLongGuan Hospital, Beijing, China
Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 50
- Registration Number
- NCT01046292
- Locations
- 🇨ðŸ‡
Basel University Hospital, Basel Mobility Center, Basel, Basel-Stadt, Switzerland
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2014-06-06
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 120
- Registration Number
- NCT00841321
- Locations
- 🇺🇸
Portland VA Medical Center, Portland, OR, Portland, Oregon, United States
🇺🇸VA Puget Sound Health Care System, Seattle, Seattle, Washington, United States
Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)
- First Posted Date
- 2003-10-13
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 50
- Registration Number
- NCT00070954
- Locations
- 🇺🇸
UMDNJ - NJ Medical School, Newark, New Jersey, United States
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 226
- Registration Number
- NCT00046891
- Locations
- 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸St. John Macomb Hospital, Warren, Michigan, United States
🇺🇸Hurley Medical Center, Flint, Michigan, United States
Effect of Ginkgo Biloba on Phenytoin Elimination
- Conditions
- First Posted Date
- 2002-12-10
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 12
- Registration Number
- NCT00011063
- Locations
- 🇺🇸
Warren G. Magnuson Clinical Center (CC), Bethesda, Maryland, United States
Treatment for Early Memory Loss
- Conditions
- First Posted Date
- 2002-07-26
- Last Posted Date
- 2014-03-03
- Lead Sponsor
- University of Iowa
- Target Recruit Count
- 40
- Registration Number
- NCT00042172
- Locations
- 🇺🇸
University of Iowa Department of Psychiatry, Iowa City, Iowa, United States
Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
- Conditions
- Locations
- 🇺🇸
University of Texas, Austin, Austin, Texas, United States
Ginkgo Biloba Extract and the Insulin Resistance Syndrome
- Conditions
- First Posted Date
- 2002-03-22
- Last Posted Date
- 2006-08-18
- Target Recruit Count
- 150
- Registration Number
- NCT00032474
- Locations
- 🇺🇸
University of Texas Health Sciences Center, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.